TrialSignal transduction and targeted therapy2026
Safety and efficacy of human gingiva-derived mesenchymal stem cells in patients with type 1 diabetes: a double-blind, randomized, placebo-controlled, phase 1 trial.
Qi Tang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.